Leveraging Old Hepatitis C Therapies

S S. Sean Tu (University of Alabama School of Law, Tuscaloosa) S Shyamasundaran Kottilil (From West Virginia University College of Law, Morgantown (S.S.T.), the Institute of Human Virology, University of Maryland School of Medicine, Baltimore (S.K.), and the Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City (T.J.M.).) T T. Joseph Mattingly (From West Virginia University College of Law, Morgantown (S.S.T.), the Institute of Human Virology, University of Maryland School of Medicine, Baltimore (S.K.), and the Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City (T.J.M.).)

Article Details

Volume / Issue Vol. 392, Issue 1
Published January 02, 2025
Pages 1-4
ISSN 0028-4793
Publisher Massachusetts Medical Society

Journal Info

New England Journal of Medicine

Massachusetts Medical Society

ISSN: 0028-4793 Social Sciences

Authors (3)

S

S. Sean Tu

University of Alabama School of Law, Tuscaloosa

S

Shyamasundaran Kottilil

From West Virginia University College of Law, Morgantown (S.S.T.), the Institute of Human Virology, University of Maryland School of Medicine, Baltimore (S.K.), and the Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City (T.J.M.).

T

T. Joseph Mattingly

From West Virginia University College of Law, Morgantown (S.S.T.), the Institute of Human Virology, University of Maryland School of Medicine, Baltimore (S.K.), and the Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City (T.J.M.).